Skip to content
OpenCapital
Get started

TELA Bio TELA Q1 2025 earnings

Reported May 8, 2025 · After market close

Revenue$18.5MBeat by $1.2M
EPS-$0.25Miss by $0.04
Revenue estimate$17.4M
EPS estimate-$0.21

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$20.0M
EPS estimate-$0.17

Versus estimates

Revenue

Q1 2026$19.1MBeat by $462.3KQ4 2025$20.9MMiss by $165.2KQ3 2025$20.7MMiss by $352.4KQ2 2025$20.2MMiss by $1.9M
Q1 2025$18.5MBeat by $1.2M
Q4 2024$17.6MMiss by $3.4M

Diluted EPS

Q1 2026-$0.21Miss by $0.07Q4 2025-$0.16Beat by $0.02Q3 2025-$0.19Miss by $0.02Q2 2025-$0.22Miss by $0.04
Q1 2025-$0.25Miss by $0.04
Q4 2024-$0.23Beat by $0.01

Ask the moment TELA Bio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did TELA Bio report Q1 2025 earnings?
TELA Bio (TELA) reported Q1 2025 earnings on May 8, 2025 after market close.
What were TELA Bio's Q1 2025 revenue and EPS?
TELA Bio reported revenue of $18.5M and eps of $-0.25 for Q1 2025.
Did TELA Bio beat estimates in Q1 2025?
Revenue beat the consensus estimate of $17.4M by $1.2M. EPS missed the consensus estimate of $-0.21 by $0.04.
How did TELA Bio's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.5% from $16.6M a year earlier and eps declined 8.7% from $-0.23.
Where can I find TELA Bio's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001558370-25-006994) directly on SEC EDGAR. The filing index links above go to sec.gov.